5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine

C62H75B2Cl2N21O5 — CID 158350313

IUPAC5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine
SMILESCB(O)N1CCN(c2ccc(Cl)nc2)CC1.CB(O)N1CCN(c2ccc(Nc3ncc4c5ccncc5n(C5CCOCC5)c4n3)nc2)CC1.Nc1ncc(-c2ccncc2Cl)c(NC2CCOCC2)n1.Nc1ncc2c3ccncc3n(C3CCOCC3)c2n1
InChIInChI=1S/C24H29BN8O2.C14H16ClN5O.C14H15N5O.C10H15BClN3O/c1-25(34)32-10-8-31(9-11-32)18-2-3-22(27-14-18)29-24-28-15-20-19-4-7-26-16-21(19)33(23(20)30-24)17-5-12-35-13-6-17;15-12-8-17-4-1-10(12)11-7-18-14(16)20-13(11)19-9-2-5-21-6-3-9;15-14-17-7-11-10-1-4-16-8-12(10)19(13(11)18-14)9-2-5-20-6-3-9;1-11(16)15-6-4-14(5-7-15)9-2-3-10(12)13-8-9/h2-4,7,14-17,34H,5-6,8-13H2,1H3,(H,27,28,29,30);1,4,7-9H,2-3,5-6H2,(H3,16,18,19,20);1,4,7-9H,2-3,5-6H2,(H2,15,17,18);2-3,8,16H,4-7H2,1H3
InChIKeyGSFQNIORLYQENB-UHFFFAOYSA-N
MW1286.95 g/mol
LogP7.95
Rot. Bonds11

About 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine

5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine (PubChem CID 158350313) has the molecular formula C62H75B2Cl2N21O5 and a molecular weight of 1286.95 g/mol. Its IUPAC name is 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine.

Molecular Properties

Compound Name5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine
PubChem CID158350313
Molecular FormulaC62H75B2Cl2N21O5
Molecular Weight1286.95 g/mol
Exact Mass1285.58
IUPAC Name5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine
SMILESCB(O)N1CCN(c2ccc(Cl)nc2)CC1.CB(O)N1CCN(c2ccc(Nc3ncc4c5ccncc5n(C5CCOCC5)c4n3)nc2)CC1.Nc1ncc(-c2ccncc2Cl)c(NC2CCOCC2)n1.Nc1ncc2c3ccncc3n(C3CCOCC3)c2n1
InChIInChI=1S/C24H29BN8O2.C14H16ClN5O.C14H15N5O.C10H15BClN3O/c1-25(34)32-10-8-31(9-11-32)18-2-3-22(27-14-18)29-24-28-15-20-19-4-7-26-16-21(19)33(23(20)30-24)17-5-12-35-13-6-17;15-12-8-17-4-1-10(12)11-7-18-14(16)20-13(11)19-9-2-5-21-6-3-9;15-14-17-7-11-10-1-4-16-8-12(10)19(13(11)18-14)9-2-5-20-6-3-9;1-11(16)15-6-4-14(5-7-15)9-2-3-10(12)13-8-9/h2-4,7,14-17,34H,5-6,8-13H2,1H3,(H,27,28,29,30);1,4,7-9H,2-3,5-6H2,(H3,16,18,19,20);1,4,7-9H,2-3,5-6H2,(H2,15,17,18);2-3,8,16H,4-7H2,1H3
InChIKeyGSFQNIORLYQENB-UHFFFAOYSA-N
XLogP7.95
TPSA308.86 Ų
H-Bond Donors6
H-Bond Acceptors26
Rotatable Bonds11
Heavy Atoms92
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001286.95
LogP ≤ 57.95
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine?
The IUPAC name of 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine (CID 158350313) is 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine.
What is the SMILES notation for 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine?
The canonical SMILES for 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine is CB(O)N1CCN(c2ccc(Cl)nc2)CC1.CB(O)N1CCN(c2ccc(Nc3ncc4c5ccncc5n(C5CCOCC5)c4n3)nc2)CC1.Nc1ncc(-c2ccncc2Cl)c(NC2CCOCC2)n1.Nc1ncc2c3ccncc3n(C3CCOCC3)c2n1.
What is the InChIKey of 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine?
The InChIKey is GSFQNIORLYQENB-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H29BN8O2.C14H16ClN5O.C14H15N5O.C10H15BClN3O/c1-25(34)32-10-8-31(9-11-32)18-2-3-22(27-14-18)29-24-28-15-20-19-4-7-26-16-21(19)33(23(20)30-24)17-5-12-35-13-6-17;15-12-8-17-4-1-10(12)11-7-18-14(16)20-13(11)19-9-2-5-21-6-3-9;15-14-17-7-11-10-1-4-16-8-12(10)19(13(11)18-14)9-2-5-20-6-3-9;1-11(16)15-6-4-14(5-7-15)9-2-3-10(12)13-8-9/h2-4,7,14-17,34H,5-6,8-13H2,1H3,(H,27,28,29,30);1,4,7-9H,2-3,5-6H2,(H3,16,18,19,20);1,4,7-9H,2-3,5-6H2,(H2,15,17,18);2-3,8,16H,4-7H2,1H3.
What are the key properties of 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine?
5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine has a molecular weight of 1286.95 g/mol, XLogP of 7.95, 11 rotatable bonds, 6 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(3-chloro-4-pyridinyl)-4-N-(oxan-4-yl)pyrimidine-2,4-diamine;[4-(6-chloro-3-pyridinyl)piperazin-1-yl]-methylborinic acid;methyl-[4-[6-[[8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-3-pyridinyl]piperazin-1-yl]borinic acid;8-(oxan-4-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine is sourced from PubChem (CID 158350313), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).